These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33489872)

  • 21. Expression of REG4 in ovarian mucinous tumors.
    Huang Q; Chen X; Lu W; Lai M; Lu B
    Appl Immunohistochem Mol Morphol; 2014 Apr; 22(4):295-301. PubMed ID: 23958547
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Gao L; Wu X; Zhang L; Dai Y; Zhu Z; Zhi Y; Wang K
    Onco Targets Ther; 2021; 14():1605-1611. PubMed ID: 33688207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reg4 protects against acinar cell necrosis in experimental pancreatitis.
    Hu G; Shen J; Cheng L; Guo C; Xu X; Wang F; Huang L; Yang L; He M; Xiang D; Zhu S; Wu M; Yu Y; Han W; Wang X
    Gut; 2011 Jun; 60(6):820-8. PubMed ID: 21193457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. REG4, NEIL2, and BIRC5 gene expression correlates with gamma-radiation sensitivity in patients with rectal cancer receiving radiotherapy.
    Kobunai T; Watanabe T; Fukusato T
    Anticancer Res; 2011 Dec; 31(12):4147-53. PubMed ID: 22199273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of
    Koh I; Nosaka S; Sekine M; Sugimoto J; Hirata E; Kudo Y
    Cancer Genomics Proteomics; 2019; 16(6):481-490. PubMed ID: 31659102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A mutant KRAS-induced factor REG4 promotes cancer stem cell properties via Wnt/β-catenin signaling.
    Hwang JH; Yoon J; Cho YH; Cha PH; Park JC; Choi KY
    Int J Cancer; 2020 May; 146(10):2877-2890. PubMed ID: 31605540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. REG4 Is Highly Expressed in Mucinous Ovarian Cancer: A Potential Novel Serum Biomarker.
    Lehtinen L; Vesterkvist P; Roering P; Korpela T; Hattara L; Kaipio K; Mpindi JP; Hynninen J; Auranen A; Davidson B; Haglund C; Iljin K; Grenman S; Siitari H; Carpen O
    PLoS One; 2016; 11(3):e0151590. PubMed ID: 26981633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
    Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
    Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Identification of gene biomarkers to predict responses to neoadjuvant chemoradiotherapy in patients with rectal cancer and pathways enrichment analysis].
    Wang XJ; Yu Q; Chi P; Lin HM; Lu XR; Huang Y; Xu ZB; Huang SH; Sun YW; Ye DX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1183-1187. PubMed ID: 31874536
    [No Abstract]   [Full Text] [Related]  

  • 30. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
    Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y
    Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ring finger protein 125, as a potential highly aggressive and unfavorable prognostic biomarker, promotes the invasion and metastasis of human gallbladder cancers via activating the TGF- β1-SMAD3-ID1 signaling pathway.
    Liu ZY; Cao J; Zhang JT; Xu GL; Li XP; Wang FT; Ansari KH; Mohamed H; Fan YZ
    Oncotarget; 2017 Jul; 8(30):49897-49914. PubMed ID: 28611292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PCAT-1: A pivotal oncogenic long non-coding RNA in human cancers.
    Yang Z; Zhao S; Zhou X; Zhao H; Jiang X
    Biomed Pharmacother; 2019 Feb; 110():493-499. PubMed ID: 30530229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RASAL2 Plays Inconsistent Roles in Different Cancers.
    Zhou B; Zhu W; Jiang X; Ren C
    Front Oncol; 2019; 9():1235. PubMed ID: 31799194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zinc finger antisense 1: A long noncoding RNA with complex roles in human cancers.
    Jiang X; Yang Z; Li Z
    Gene; 2019 Mar; 688():26-33. PubMed ID: 30503395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptome dissection of gastric cancer: identification of novel diagnostic and therapeutic targets from pathology specimens.
    Yasui W; Oue N; Sentani K; Sakamoto N; Motoshita J
    Pathol Int; 2009 Mar; 59(3):121-36. PubMed ID: 19261089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regenerating islet-derived family member, 4 modulates multiple receptor tyrosine kinases and mediators of drug resistance in cancer.
    Vanderlaag K; Wang W; Fayadat-Dilman L; Wagner J; Bald L; Grein J; Janatpour MJ
    Int J Cancer; 2012 Mar; 130(6):1251-63. PubMed ID: 21445968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-10b is a prognostic indicator in colorectal cancer and confers resistance to the chemotherapeutic agent 5-fluorouracil in colorectal cancer cells.
    Nishida N; Yamashita S; Mimori K; Sudo T; Tanaka F; Shibata K; Yamamoto H; Ishii H; Doki Y; Mori M
    Ann Surg Oncol; 2012 Sep; 19(9):3065-71. PubMed ID: 22322955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The progress of circular RNAs in various tumors.
    Wang D; Yang S; Wang H; Wang J; Zhang Q; Zhou S; He Y; Zhang H; Deng F; Xu H; Zhong S; Fu L; Tang J
    Am J Transl Res; 2018; 10(6):1571-1582. PubMed ID: 30018701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression and clinical significance of fibroblast growth factor 1 in gastric adenocarcinoma.
    Liu N; Zhang J; Sun S; Yang L; Zhou Z; Sun Q; Niu J
    Onco Targets Ther; 2015; 8():615-21. PubMed ID: 25792845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.